Compass therapeutics to participate in the piper sandler 36th annual healthcare conference

Boston, dec. 02, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will present at the piper sandler 36th annual healthcare conference taking place in new york city, ny december 3-5, 2024.
CMPX Ratings Summary
CMPX Quant Ranking